PFG Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$652K Buy
1,685
+297
+21% +$110K 0.03% 554
2026
Q1
$406K Buy
1,388
+13
+0.9% +$4.27K 0.02% 696
2025
Q4
$482K Sell
1,375
-57
-4% -$19.3K 0.02% 584
2025
Q3
$463K Buy
1,432
+24
+2% +$7.46K 0.02% 576
2025
Q2
$548K Buy
1,408
+70
+5% +$28.2K 0.03% 491
2025
Q1
$582K Buy
1,338
+1
+0.1% +$401 0.04% 439
2024
Q4
$493K Buy
1,337
+4
+0.3% +$1.67K 0.03% 502
2024
Q3
$693K Buy
1,333
+561
+73% +$300K 0.04% 382
2024
Q2
$418K Buy
772
+2
+0.3% +$1.06K 0.03% 519
2024
Q1
$399K Buy
+770
New +$383K 0.02% 628

Other funds holding ELV

PFG Investments's ELV Position: Q2 2026 in Review

PFG Investments increased its Elevance Health (ELV) stake by 21% in Q2 2026, buying an estimated $110K and bringing the position to 1,685 shares worth $652K. The position accounts for 0.03% of the portfolio, ranked #554.

PFG Investments first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $693K in Q3 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PFG Investments held 1,685 shares of Elevance Health worth $652K as of Q2 2026.
  • PFG Investments bought 297 Elevance Health shares in Q2 2026, an estimated $110K.
  • Elevance Health made up 0.03% of PFG Investments's portfolio in Q2 2026, its #554 holding.
  • PFG Investments first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • PFG Investments's Elevance Health position peaked at $693K in Q3 2024.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.